Philips provides update on composition of its Supervisory Board
14 Dezembro 2021 - 05:00AM
Philips provides update on composition of its Supervisory Board
December 14, 2021
- Herna Verhagen and Sanjay Poonen proposed as new members of
Philips’ Supervisory Board
- Paul Stoffels and Marc Harrison proposed for re-appointment as
members of the Supervisory Board
- Neelam Dhawan to retire from the Supervisory Board after third
consecutive term
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG; AEX: PHIA), a global leader in health technology, today
announced that its Supervisory Board will propose the appointments
of Mrs. Herna Verhagen and Mr. Sanjay Poonen as new members of the
Supervisory Board at the Annual General Meeting of Shareholders
(AGM), which will be held on May 10, 2022. Furthermore, Dr. Paul
Stoffels and Dr. Marc Harrison, whose first terms expire in 2022,
will be proposed for re-appointment as members of the Supervisory
Board. Mrs. Neelam Dhawan, who joined Philips’ Supervisory Board in
2012, will retire from the Board after her third consecutive term,
effective upon closing of the 2022 AGM.
“We are very pleased to nominate Mrs. Herna Verhagen and Mr.
Sanjay Poonen as new members of Philips’ Supervisory Board,
supporting the company to deliver on its purpose of improving
people’s health and well-being through innovation,” said Feike
Sijbesma, Chairman of the Supervisory Board of Royal Philips. “With
her proven track record in driving a customer-first company culture
and a background in e-commerce logistics, Mrs. Verhagen will bring
valued and new perspectives to the Supervisory Board, while Mr.
Poonen’s extensive experience in enterprise IT will further
strengthen the Supervisory Board’s digital competencies.”
“We are also very pleased that Dr. Paul Stoffels, the current
Vice Chair, and Dr. Marc Harrison remain available as members of
the Board,” added Mr. Sijbesma. “Their expertise and experience in
healthcare innovation is extremely valuable as Philips aims to
support the transformation of healthcare with new health technology
solutions along the health continuum.”
“On behalf of the Executive Committee and the Supervisory Board,
I would like to express my deep gratitude to Neelam Dhawan for her
long-term counsel and support since 2012,” said Frans van Houten,
CEO of Royal Philips. “Her in-depth knowledge of the IT industry,
including research, software engineering, and services has been
indispensable during Philips’ transformation into a health
technology leader. We look forward to continue to grow Philips,
supported by a diverse and experienced Supervisory Board, aiming to
support consumers to lead a healthy life and our healthcare
customers achieve the Quadruple Aim of better health outcomes,
improved patient and staff experiences, and lower cost of
care.”
Mrs. Verhagen (Dutch, 1966) has been CEO and Chair of the Board
of Management of PostNL since 2012. Under her leadership, PostNL
executed a strategic transformation from a mail delivery company
into a growing postal and e-commerce logistic solutions provider.
Prior to her role as CEO, Mrs. Verhagen served as a member of the
Management Board of PostNL, and was Managing Director Parcels and
International PostNL.
Mr. Poonen (American, 1969) has held various executive
leadership positions in the software industry, including most
recently as Chief Operating Officer for cloud computing company
VMware. In this role he was responsible for all business functions,
including sales, services, support, marketing and alliances
including strategic agreements with Amazon, Microsoft and Google.
Prior to VMware, he was President at SAP, where he led analytics,
data management and vertical industry solutions.
Subject to AGM approval, Mrs. Verhagen and Mr. Poonen will join
a diverse and experienced Supervisory Board, consisting of members
from Europe, North America and Asia with wide-ranging business
experiences, including in the medical technology, healthcare,
pharmaceuticals, IT, engineering and consumer goods industries. For
more information about Philips’ Supervisory Board, please follow
this link.
For further information, please
contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 6 1521 3446E-mail:
ben.zwirs@philips.com
Derya GuzelPhilips Investor RelationsTel.: +31 20 59
77055E-mail: derya.guzel@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being, and enabling better
outcomes across the health continuum – from healthy living and
prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer
insights to deliver integrated solutions. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2020
sales of EUR 17.3 billion and employs approximately 78,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Forward-looking statements
This release contains certain forward-looking statements with
respect to the financial condition, results of operations and
business of Philips and certain of the plans and objectives of
Philips with respect to these items. Examples of forward-looking
statements include statements made about the strategy, estimates of
sales growth, future EBITA, future developments in Philips’ organic
business and the completion of acquisitions and divestments. By
their nature, these statements involve risk and uncertainty because
they relate to future events and circumstances and there are many
factors that could cause actual results and developments to differ
materially from those expressed or implied by these
statements.
- Herna Verhagen (photo by Serge Ligtenberg)
- Sanjay Poonen
- Marc Harrison
- Paul Stoffels
- Neelam Dhawan
Koninklijke Philips NV (BIT:1PHIA)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Koninklijke Philips NV (BIT:1PHIA)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024